PTEN/MMAC1 expression in melanoma resection specimens

British Journal of Cancer

Volumn 87, Issue 12, 2002, Pages 1431-1436

  Deichmann, Martin ^a   Thome, M ^a   Benner, A ^b   Egner, U ^a   Hartschuh, W ^a   Naher H ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Melanoma; PTEN MMAC1; Tumour suppressor gene

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER SURGERY; CHROMOSOME; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; DOWN REGULATION; GENE DELETION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 10; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MELANOCYTES; MELANOMA; MIDDLE AGED; MUTATION; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037011674     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600653     Document Type: Article

References (46)

1. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK (1994) Mutation and expression of the p53 gene in human malignant melanomas. Melanoma Res 4: 35-45
2. Ali IU, Schriml LM, Dean M (1999) Mutational spectra of PTEN/MMAC1 gene, a tumour suppressor with lipid phosphatase activity. J Natl Cancer Inst 91: 1922-1931
3. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D (1998) Chromosomal gains and losses in primary, cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58: 2170-2175
4. Birck A, Ahrenkiel V, Zeuthen J, Hou-Jensen K, Guldberg P (2000) Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol 114: 277-280
5. Böni R, Vortmeyer AO, Burg G, Hofbauer G, Zhuang Z (1998) The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res 8: 300-302
6. Bonneau D, Longy M (2000) Mutations of the human PTEN gene. Hum Mut 16: 109-122
7. Celebi JT, Shendrik I, Silvers DN, Peacocke M (2000) Identification of PTEN mutations in metastatic melanoma specimens. J Mol Genet 37: 653-657
8. Di Cristofano A, Pandolfino PP (2000) The multiple roles of PTEN in tumour suppression. Cell 100: 387-390
9. Endege WO, Steinmann KE, Boardman LA, Thibodeau SN, Schlegel R (1999) Representative cDNA libraries and their utility in gene expression profiling. BioTechniques 26: 542-550
10. Guldberg P, Straten PT, Brick A, Ahrenkiel V, Kirkin AF, Zeuthen J (1997) Disruption of the MMACI/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663
11. Healy E, Belgaid CE, Takata M, Vahlquist A, Rehman I, Rigby H, Rees JL (1996) Allotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res 56: 589-593
12. Healy E, Belgaid CE, Takata M, Harrison D, Zhu NW, Burd DA, Rigby HS, Matthews JN, Rees JL (1998) Prognostic significance of allelic losses in primary, melanoma. Oncogene 16: 2213-2218
13. Herbst RA, Weiss J, Ehnis A, Cavenee WK, Arden KC (1994) Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54: 3111-3114
14. Herbst RA, Podewski EK, Mommert S, Kapp A, Weiss J (1999) PTEN and MXII allelic loss on chromosome 10q is rare in melanoma in vivo. Arch Dermatol Res 291: 567-569
15. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29: 577
16. Hsu SM, Soban E (1982) Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 30: 1079
17. Indsto JO, Holland EA, Kefford RF, Mann GJ (1998) 10 q deletions in metastatic cutaneous melanoma. Cancer Genet Cytogenet 100: 68-71
18. Isshiki K, Elder DE, Guerry D, Linnenbach AJ (1993) Chromosome 10 allelic loss in malignant melanoma. Genes Chrom Cancer 8: 178-184
19. Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP (2000) Analysis of the cellular functions of PTEN using catalytic domain and C-terminal mutations, differential effects of C-terminal deletion on signalling pathways downstream of phosphoinositide 3-kinase. Biochem J 346: 827-833
20. Leslie NR, Bennett D, Gray A, Pass I, Hoang-Xuan K, Downes CP (2001) Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions. Biochem J 357: 427-435
21. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Millaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 275: 1943-1947
22. Liu J, Kagan J (1999) Method to distinguish between the MMACI/PTEN gene and its pseudogene in RT-PCR analysis of point mutations. BioTechniques 26: 19-24
23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748
24. Montell C (1998) TRP trapped in fly signaling weg. Curr Opin Neurobiol 8: 389-397
25. Morimoto AM, Berson AE, Fujii GH, Teng DH, Tavtigian SV, Bookstein R, Steck PA, Bolen JB (1999) Phenotypic analysis of human glioma cells expressing the MMACI tumor suppressor phosphatase. Oncogene 18: 1261-1266
26. Nagase S, Sato S, Tezuka F, Wada Y, Yajima A, Horii A (1996) Deletion mapping on chromosome 10q25-q26 in human endometrial cancer. Br J Cancer 74: 1979-1983
27. Nelen MR, Padberg GW, Peeters EA, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MM, Easton DF, Eeles RA, Hodgsen S, Mulvihill JJ, Murday VA, Trucker MA, Marimam EC, Starink TM, Ponder BA, Ropers HH, Kremer H, Longy M, Eng C (1996) Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 13: 114-116
28. Nemoto Y, De Camilli P (1999) Recruitment of an alternatively spliced form of synaptojanin 2 to mitochondria by the interaction with the PDZ domain of a mitochondrial outer membrane protein. EMBO J 18: 2991-3006
29. Newton JA (1994) Genetics of melanoma. Br Med Bull 50: 677-687
30. Parmiter AH, Balaban G, Clark Jr WH, Nowell PC (1988) Possible involvement of the chromosome region 10q24-q26 in early stages of melanocytic neoplasia. Cancer Genet Cytogenet 30: 313-317
31. Poetsch M, Dittberner T, Woenckhaus C (2001) PTEN/MMAC1 in malignant melanoma and its importance for tumor progression. Cancer Genet Cytogenet 125: 21-26
32. Ponte P, Ng S, Engel J, Gunning P, Kedes L (1984) Evolutionary, conservation in the untranslated regions of actin mRNAs, DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 12: 1687-1696
33. Raskind WH, Conrad EU, Matsushita M (1996) Frequent loss of heterozygosity for markers on chromosome arm 10q in chondrosarkomas. Genes Chrom Cancer 16: 138-143
34. Reifenberger J, Wolter M, Bostrom J, Buschges R, Schulte KW, Megahed M, Ruzicka T, Reifenberger G (2000) Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch 436: 487-493
35. Richmond A, Fine R, Murray D, Lawson DH, Priest JH (1986) Growth factor and cytogenetic abnormalities in cultured nevi and malignant melanomas. J Invest Dermatol 86: 295-302
36. Rigel DS, Frieman RJ, Kopf AW (1996) The incidence of malignant melanoma in the United States, issues as we approach the 21st century. J Am Acad Dermatol 34: 839-847
37. Robertson GP, Herbst RA, Nagane M, Huang HJ, Cavenee WK (1999) The chromosome 10 monosomy common in human melanoma results from loss of two separate tumor suppressor loci. Cancer Res 59: 3596-3601
38. Speicher MR, Schoell B, du Manoir S, Schröck E, Ried T, Cremer T, Störkel S, Kovacs A, Kovacs G (1994) Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145: 356-364
39. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advances cancers. Nature Genet 15: 356-362
40. Teng DHF, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.. Cancer Res 57: 5221-5225
41. Trybus TM, Burgess AC, Wojno KJ, Glover TW, Macoska JA (1996) Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56: 2263-2267
42. Tsao H, Zhang X, Benoit E, Haluska FG (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16: 3397-3402
43. Tsao H, Zhang X, Fowlkes K, Haluska FG (2000) Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines. Cancer Res 60: 1800-1804
44. Walker GJ, Palmer JM, Walters MK, Hayward NK (1995) A genetic model of melanoma tumorigenesis based on allelic loss. Genes Chrom. Cancer 12: 134-141
45. Wang NM, Chang JG, Liu TC, Lin SF, Peng CT, Tsai FJ, Tsai CH (2000) Abberant transcripts of FHIT, TSG101 and PTEN/MMAC1 genes in normal peripheral mononuclear cells. Int J Oncol 16: 75-80
46. Zhou XP, Grimm O, Hampel H, Niemann T, Walker MJ, Eng C (2000) Epigentic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol 157: 1123-1128